Journal of Andrology Free Medline Services
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luke, M. C.
Right arrow Articles by Coffey, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luke, M. C.
Right arrow Articles by Coffey, D. S.

Journal of Andrology, Vol 15, Issue 1 41-51, Copyright © 1994 by The American Society of Andrology


JOURNAL ARTICLE

Human androgen receptor binding to the androgen response element of prostate specific antigen

M. C. Luke and D. S. Coffey
Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.

This study examined the in vitro interaction of the human androgen receptor with a putative androgen response element (ARE) in the promoter region of the prostate specific antigen (PSA) gene. To characterize the androgen receptor's interactions with its DNA response elements we expressed the full length human androgen receptor protein in a baculovirus expression system. The receptor was shown to be 110 kDa by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and was purified using ion-exchange column chromatography. Binding of the synthetic androgen R1881 to the unpurified recombinant receptor exhibited a kd of 7.6 nM by Scatchard analysis. In DNA gel electromobility shift assays the promoter region from PSA (a 313-bp fragment) was bound by the unpurified recombinant androgen receptor in a sequence-specific manner. An ARE-containing sequence from the promoter region of the PSA gene was synthesized as a 30-bp oligonucleotide and was shown to bind specifically to the human androgen receptor in gel electromobility shift assays by DNA competition and by antibody supershifts of the receptor-ARE complex. The specific binding of the insect cell expressed androgen receptor to its ARE was shown to occur even in the absence of androgen. Androgen receptors purified by ion-exchange chromatography were unable to bind to ARE, suggesting the presence of other factors required for DNA binding.


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner
Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens
Endocrinology, March 1, 2008; 149(3): 1103 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. K. Potter, M. G. Zager, and H. A. Barton
Mathematical model for the androgenic regulation of the prostate in intact and castrated adult male rats
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E952 - E964.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
W. H Walker and J. Cheng
FSH and testosterone signaling in Sertoli cells
Reproduction, July 1, 2005; 130(1): 15 - 28.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Krishnan, H. A. Bullock, B. C. Yaden, M. Liu, R. J. Barr, C. Montrose-Rafizadeh, K. Chen, J. A. Dodge, and H. U. Bryant
The Nongenotropic Synthetic Ligand 4-Estren-3{alpha}17{beta}-diol Is a High-Affinity Genotropic Androgen Receptor Agonist
Mol. Pharmacol., March 1, 2005; 67(3): 744 - 748.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. P. Burris, C. Montrose, K. A. Houck, H. E. Osborne, W. P. Bocchinfuso, B. C. Yaden, C. C. Cheng, R. W. Zink, R. J. Barr, C. D. Hepler, et al.
The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
Mol. Pharmacol., March 1, 2005; 67(3): 948 - 954.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. J. James, I. U. Agoulnik, J. M. Harris, G. Buchanan, W. D. Tilley, M. Marcelli, D. J. Lamb, and N. L. Weigel
A Novel Androgen Receptor Mutant, A748T, Exhibits Hormone Concentration-Dependent Defects in Nuclear Accumulation and Activity Despite Normal Hormone-Binding Affinity
Mol. Endocrinol., December 1, 2002; 16(12): 2692 - 2705.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z.-Q. Huang, J. Li, and J. Wong
AR Possesses an Intrinsic Hormone-Independent Transcriptional Activity
Mol. Endocrinol., May 1, 2002; 16(5): 924 - 937.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. M. Yousef and E. P. Diamandis
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease
Endocr. Rev., April 1, 2001; 22(2): 184 - 204.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
S. C. Dixon, K. B. Knopf, and W. D. Figg
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
Pharmacol. Rev., March 1, 2001; 53(1): 73 - 92.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Huang, Y. Shostak, P. Tarr, C. Sawyers, and M. Carey
Cooperative Assembly of Androgen Receptor into a Nucleoprotein Complex That Regulates the Prostate-specific Antigen Enhancer
J. Biol. Chem., September 3, 1999; 274(36): 25756 - 25768.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. H. H. Goh
Breast Tissues in Transsexual Women-A Nonprostatic Source of Androgen Up-Regulated Production of Prostate-Specific Antigen
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3313 - 3315.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
N. Zarghami, L. Grass, E. R. Sauter, and E. P. Diamandis
Prostate-specific antigen in serum during the menstrual cycle
Clin. Chem., October 1, 1997; 43(10): 1862 - 1867.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. N. Melegos, H. Yu, M. Ashok, C. Wang, F. Stanczyk, and E. P. Diamandis
Prostate-Specific Antigen in Female Serum, a Potential New Marker of Androgen Excess
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 777 - 780.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The American Society of Andrology.